首页> 外文期刊>Cancer radiotherapie: journal de la Soci閠?fran鏰ise de radiotherapie oncologique >Which node area should be irradiated after neoadjuvant chemotherapy in breast cancer?
【24h】

Which node area should be irradiated after neoadjuvant chemotherapy in breast cancer?

机译:乳腺癌新辅助化疗后应照射哪个淋巴结区域?

获取原文
获取原文并翻译 | 示例
       

摘要

In addition to achieve breast conserving surgery after neoadjuvant chemotherapy, its indications are growing, especially in Her2 overexpressing and triple negative breast cancers owing to the emergence of new targeted therapies. Radiotherapy belongs to breast cancer management. However, some questions are still unresolved regarding nodes area irradiation after neoadjuvant chemotherapy. This short communication reviews indications of radiotherapy of node areas in breast cancer after neoadjuvant chemotherapy. (C) 2015 Societe francaise de radiotherapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.
机译:除了在新辅助化疗后实现保乳手术外,由于新靶向疗法的出现,其适应症还在增加,尤其是在Her2过表达和三阴性乳腺癌中。放射治疗属于乳腺癌管理。然而,关于新辅助化疗后的结节区域照射,仍有一些问题尚未解决。这段简短的交流回顾了新辅助化疗后乳腺癌淋巴结区域放疗的适应症。 (C)2015年法国放射疗法肿瘤学学会(SFRO)。由Elsevier Masson SAS发布。版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号